Express Scripts and Walgreens Boots Alliance, Inc., say they will work to include specialty drugs in their group purchasing efforts.
According to a Center for Biosimilars report, the drugs would include biologics and biosimilars. The partnership, according to the report, will look to ValoremRx Specialty Solutions to source specialty drugs.
“Specialty medications represent the most costly and complex drugs,” Express Scripts President and CEO Tim Wentworth said in a statement. “By expanding our efforts with Walgreens Boots Alliance, we will improve our supply chain and ultimately make the use of these medicines, including biosimilars, more affordable and accessible for our patients and clients.”
“As prescription drug needs evolve and specialty medications are prescribed more often, we continue to look for new solutions that will help our patients get the medications they need at an affordable price,” Walgreens Boots Alliance Co-COO Alex Gourlay said.